000			01956 a2200505 4500
005			20250513192207.0
264		0	_c19990917
008			199909s 0 0 eng d
022			_a0171-5216
024	7		_a10.1007/s004320050301 _2doi
040			_aNLM _beng _cNLM
100	1		_aSzepesházi, K
245	0	0	_aGrowth inhibition of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs. _h[electronic resource]
260			_bJournal of cancer research and clinical oncology _c
300			_a444-52 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents, Hormonal _xtherapeutic use
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBombesin _xanalogs & derivatives
650	0	4	_aCricetinae
650	0	4	_aDisease Models, Animal
650	0	4	_aDown-Regulation _xdrug effects
650	0	4	_aErbB Receptors _xdrug effects
650	0	4	_aEstradiol _xblood
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aGonadotropin-Releasing Hormone _xanalogs & derivatives
650	0	4	_aGrowth Hormone _xblood
650	0	4	_aLuteinizing Hormone _xblood
650	0	4	_aMesocricetus
650	0	4	_aMitotic Index _xdrug effects
650	0	4	_aNucleolus Organizer Region _xdrug effects
650	0	4	_aPancreatic Neoplasms _xblood
650	0	4	_aPeptide Fragments _xtherapeutic use
650	0	4	_aTime Factors
700	1		_aHalmos, G
700	1		_aSchally, A V
700	1		_aArencibia, J M
700	1		_aGroot, K
700	1		_aVadillo-Buenfil, M
700	1		_aRodriguez-Martin, E
773	0		_tJournal of cancer research and clinical oncology _gvol. 125 _gno. 8-9 _gp. 444-52
856	4	0	_uhttps://doi.org/10.1007/s004320050301 _zAvailable from publisher's website
999			_c10437740 _d10437740